Implants

IMPLANET Receives FDA Clearance for Its New Hybrid Fixation System Jazz Spinal SystemTM

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology…

8 months ago

Establishment Labs Reports First Quarter 2024 Financial Results

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

8 months ago

Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

8 months ago

Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

8 months ago

Monogram Provides Regulatory Update Following Meeting with FDA

510(k) Submission with FDA Accelerated for Early Second Half of 2024 AUSTIN, TX / ACCESSWIRE / May 1, 2024 /…

8 months ago

Tenon Medical, Inc. Announces Timing of First Quarter 2024 Financial Results

LOS GATOS, CA / ACCESSWIRE / April 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company…

8 months ago

Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WATERTOWN, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (the “Company” or “Lyra”), a clinical-stage biotech…

8 months ago

Curiteva Announces David Schmidt as Chief Commercial Officer

HUNTSVILLE, AL / ACCESSWIRE / April 26, 2024 / Curiteva, a privately held manufacturing and technology company, announces the appointment…

8 months ago

Minutes of IMPLANET’s Ordinary General Meeting held on April 25, 2024

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology…

8 months ago

Establishment Labs to Announce First Quarter 2024 Financial Results on May 8

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

8 months ago